ANGELICO, ROBERTA
 Distribuzione geografica
Continente #
NA - Nord America 13.867
AS - Asia 3.556
EU - Europa 2.321
SA - Sud America 541
Continente sconosciuto - Info sul continente non disponibili 465
AF - Africa 83
OC - Oceania 7
Totale 20.840
Nazione #
US - Stati Uniti d'America 13.657
SG - Singapore 1.609
IT - Italia 629
CN - Cina 529
BR - Brasile 415
RU - Federazione Russa 385
HK - Hong Kong 370
VN - Vietnam 290
BD - Bangladesh 235
GB - Regno Unito 230
DE - Germania 215
IE - Irlanda 183
FI - Finlandia 177
IN - India 129
CA - Canada 118
JP - Giappone 115
FR - Francia 105
UA - Ucraina 99
NL - Olanda 75
SE - Svezia 50
AR - Argentina 46
ID - Indonesia 46
KR - Corea 41
TR - Turchia 39
MX - Messico 38
ES - Italia 31
AT - Austria 30
PL - Polonia 30
EC - Ecuador 18
ZA - Sudafrica 18
IQ - Iraq 17
SA - Arabia Saudita 17
BE - Belgio 16
CO - Colombia 14
CZ - Repubblica Ceca 14
EG - Egitto 14
PH - Filippine 14
VE - Venezuela 14
CL - Cile 13
NG - Nigeria 13
JM - Giamaica 12
MY - Malesia 12
TH - Thailandia 12
GR - Grecia 11
HN - Honduras 9
PY - Paraguay 9
TN - Tunisia 9
UZ - Uzbekistan 9
CH - Svizzera 8
AZ - Azerbaigian 7
EU - Europa 7
IL - Israele 7
KE - Kenya 7
PK - Pakistan 7
AE - Emirati Arabi Uniti 6
AU - Australia 6
CR - Costa Rica 6
DZ - Algeria 6
HR - Croazia 6
LT - Lituania 6
MA - Marocco 6
NP - Nepal 6
PE - Perù 6
GT - Guatemala 5
JO - Giordania 5
MD - Moldavia 5
TT - Trinidad e Tobago 5
HU - Ungheria 4
NI - Nicaragua 4
SC - Seychelles 4
TM - Turkmenistan 4
UY - Uruguay 4
AM - Armenia 3
GE - Georgia 3
IR - Iran 3
KG - Kirghizistan 3
KZ - Kazakistan 3
PR - Porto Rico 3
RO - Romania 3
SV - El Salvador 3
TW - Taiwan 3
BO - Bolivia 2
DO - Repubblica Dominicana 2
EE - Estonia 2
LA - Repubblica Popolare Democratica del Laos 2
LK - Sri Lanka 2
OM - Oman 2
PT - Portogallo 2
A1 - Anonimo 1
AG - Antigua e Barbuda 1
AW - Aruba 1
BB - Barbados 1
BF - Burkina Faso 1
BH - Bahrain 1
BJ - Benin 1
CI - Costa d'Avorio 1
CU - Cuba 1
CW - ???statistics.table.value.countryCode.CW??? 1
CY - Cipro 1
DK - Danimarca 1
Totale 20.371
Città #
Wilmington 2.594
Houston 2.271
Woodbridge 2.007
Singapore 804
Ashburn 713
San Jose 526
Fairfield 431
Council Bluffs 362
Hong Kong 361
New York 361
Ann Arbor 248
Chandler 247
Beijing 232
Seattle 175
Dublin 171
Cambridge 168
Los Angeles 149
Santa Clara 149
Medford 131
Helsinki 129
The Dalles 103
Rome 101
Tokyo 97
Buffalo 94
Ho Chi Minh City 89
Elk Grove Village 86
Jacksonville 85
Moscow 76
Hanoi 69
North Bergen 64
Chicago 60
Lawrence 60
Milan 54
Lauterbourg 53
São Paulo 50
Dallas 49
Denver 42
Orem 42
Jakarta 40
San Diego 40
Boardman 38
Dearborn 37
Atlanta 34
Chennai 33
Montreal 31
Munich 31
Zhengzhou 30
Toronto 29
Frankfurt am Main 28
Brooklyn 27
Nuremberg 27
London 26
Phoenix 25
Creede 23
Redondo Beach 23
Lappeenranta 22
Amsterdam 21
Dong Ket 20
Manchester 18
Miami 18
Warsaw 18
Menlo Park 16
Poplar 16
Vienna 16
Mülheim 15
Salt Lake City 15
Seoul 15
Turin 15
Stockholm 14
Washington 14
Brasília 13
San Francisco 13
Ankara 12
Belo Horizonte 12
Da Nang 12
Istanbul 12
Johannesburg 12
Mexico City 12
Paris 12
Quito 12
Bologna 11
Rio de Janeiro 11
Engelhard 10
Madrid 10
Nanjing 10
Palermo 10
Boston 9
Brussels 9
Columbus 9
Dhaka 9
Haiphong 9
Jeddah 9
Jersey City 9
Mountain View 9
Naples 9
Santiago 9
Kuala Lumpur 8
Mumbai 8
Newark 8
Tashkent 8
Totale 14.584
Nome #
Elective surgery system strengthening: development, measurement, and validation of the surgical preparedness index across 1632 hospitals in 119 countries 728
Hepatitis C virus recurrence and immunosuppression-free state after liver transplantation. 509
Glycogen storage disease type Ia and VI associated with hepatocellular carcinoma: Two case reports 504
Impact of immunosuppression minimization and withdrawal in long-term hepatitis C virus liver transplant recipients 495
Conversion to rapamycin immunosuppression for malignancy after kidney transplantation 483
Steroid-free immunosuppression after liver transplantation does not increase the risk of graft fibrosis. 472
Management of spermatic cord liposarcoma in renal transplant recipients: case report 458
Long-term, maintenance MMF monotherapy improves the fibrosis progression in liver transplant recipients with recurrent hepatitis C 451
Prospective study of switch from cyclosporine to tacrolimus for fibroadenomas of the breast in kidney transplantation. 444
Prospective randomised comparison of Rubber Band Ligation(RBL) and Combined Hemorrhoidal Radiocoagulation(CHR) 443
Intra-graft expression of genes involved in iron homeostasis predicts the development of operational tolerance in human liver transplantation. 442
Side-to-side caval anastomosis in a patient receiving a liver graft from a marginal donor with situs inversus totalis 433
The Tor Vergata weaning of immunosuppression protocols in stable hepatitis C virus liver transplant patients: the 10-year follow-up 429
One-shot versus multidose perioperative antibiotic prophylaxis after kidney transplantation: A randomized, controlled clinical trial 428
Surgical antibiotic prophylaxis after renal transplantation: time to reconsider. 425
Ambulatory therapy with combined hemorrhoidal radiocoagulation 420
Ab initio Everolimus-based Versus Standard Calcineurin Inhibitor Immunosuppression Regimen in Liver Transplant Recipients 391
Switch from twice-daily tacrolimus (Prograf) to once-daily prolonged-release tacrolimus (Advagraf) in kidney transplantation. 388
Liver transplantation for hepatitis B and C virus-related cirrhosis: mid-term results 376
Clinical Operational Tolerance and Immunosuppression Minimization in Kidney Transplantation: Where Do We Stand? 360
Longterm Survival and Cost-Effectiveness of Immunosuppression Withdrawal After Liver Transplantation 351
Hepatitis B virus recurrence after liver transplantation: An old tale or a clear and present danger? 351
Donation after circulatory death in paediatric liver transplantation: current status and future perspectives in the machine perfusion era 332
Impact of remnant vital tissue after locoregional treatment and liver transplant in hepatocellular cancer patients, a multicentre cohort study 323
Outcomes of left split graft transplantation in Europe: report from the European Liver Transplant Registry 279
Liver Transplantation For HDV/HBV Coinfection In Italy: An Intention-To-Treat Analysis Of Long-Term Outcomes 262
A national mandatory-split liver policy: A report from the Italian experience 259
Everolimus and enteric-coated mycophenolate sodium Ab initio after liver transplantation: Midterm results 243
Aggressive prevention and preemptive management of vascular complications after pediatric liver transplantation: A major impact on graft survival and long-term outcome 235
The COVID-19 outbreak in Italy: initial implications for organ transplantation programs 232
De novo malignancies after liver transplantation: The effect of immunosuppression-personal data and review of literature 220
Screening of Fabry Disease of patients in renal replacement therapy in a population from Lazio (Italy) 209
How do synchronous lung metastases influence the surgical management of children with hepatoblastoma? An update and systematic review of the literature 206
Using a weaning immunosuppression protocol in liver transplantation recipients with hepatocellular carcinoma: A compromise between the risk of recurrence and the risk of rejection? 189
Colorectal cancer in ulcerative colitis after liver transplantation for primary sclerosing cholangitis: a systematic review and pooled analysis of oncological outcomes 180
Ante situm liver resection with inferior vena cava replacement under hypothermic cardiopolmunary bypass for hepatoblastoma: Report of a case and review of the literature 179
A matched pair analysis of multicenter longterm follow-up after split-liver transplantation with extended right grafts 174
Laparoscopic adrenalectomy for hemorrahagic adrenal pseudocyst discovered during pregnancy: Report of a case 172
Fairness and pitfalls of the Italian waiting list for elective liver transplantation: The ECALITA registry study 167
Kidney Transplantation in the Hepatitis C Infected Recipient 164
The hamletic dilemma of patients waiting for kidney transplantation during the COVID-19 pandemic: to accept or not to accept (an organ offer)? 146
Improving outcomes of in situ split liver transplantation in Italy over the last 25 years 141
Moving forward in the treatment of cholangiocarcinoma 139
Current strategies to minimize ischemia-reperfusion injury in liver transplantation: a systematic review 131
Effects of Anti-COVID-19 Vaccination and Pre-Exposure Prophylaxis with Tixagevimab-Cilgavimab in Kidney and Liver Transplant Recipients 124
Chronic rejection after liver transplantation: Opening the Pandora's box 123
The Enhanced Recovery after Surgery (ERAS) Pathway Is a Safe Journey for Kidney Transplant Recipients during the “Extended Criteria Donor” Era 121
“Salus Populi Suprema Lex”: Considerations on the Initial Response of the United Kingdom to the SARS-CoV-2 Pandemic 121
Same donor laparoscopic liver and kidney procurement for sequential living donor liver-kidney transplantation in primary hyperoxaluria type i 119
A Keynesian perspective on the health economics of kidney transplantation would strengthen the value of the whole organ donation and transplantation service 118
Safety and efficacy of simultaneous liver transplantation and sleeve gastrectomy in morbid obese patients with end-stage liver disease: the LT-SG study 117
Pancreatic Adeno-MiNEN, a Rare Newly Defined Entity with Challenging Diagnosis and Treatment: A Case Report with Systematic Literature Review and Pooled Analysis 116
Repeat laparoscopic hepatectomy for recurrent tumors is safe and feasible. An Invited Commentary on "Perioperative outcomes comparing laparoscopic with open repeat liver resection for post-hepatectomy recurrent liver cancer: a systematic review and meta-analysis" (Int J Surg 2020; Epub ahead of print) 115
Mechanism, potential, and concerns of immunotherapy for hepatocellular carcinoma and liver transplantation 114
The Enhanced Recovery After Surgery Pathway Is Safe, Feasible and Cost-Effective in Delayed Graft Function After Kidney Transplant 112
Successful clinical and virological outcomes of liver transplantation for HDV/HBV-related disease after long-term discontinuation of hepatitis B immunoglobulins 111
Pancreas exocrine replacement therapy is associated with increased survival following pancreatoduodenectomy for periampullary malignancy 110
Cell transplantation-based regenerative medicine in liver diseases 109
Current status of liver surgery for non-colorectal non-neuroendocrine liver metastases: the NON.LI.MET. Italian Society for Endoscopic Surgery and New Technologies (SICE) and Association of Italian Surgeons in Europe (ACIE) collaborative international survey 109
Is routine hepaticojejunostomy at the time of unplanned surgical bypass required in the era of self-expanding metal stents? 108
Combined endovascular-surgical treatment for complex congenital intrahepatic arterioportal fistula: A case report and review of the literature 107
Intraductal Papillary Neoplasms of the Bile Duct: Clinical Case Insights and Literature Review 106
Liver transplantation performed in a SARS-CoV-2 positive hospitalized recipient using a SARS-CoV-2 infected donor 106
A novel mobile phone application for infant stool color recognition: An easy and effective tool to identify acholic stools in newborns 106
Hepatocellular carcinoma in children: Hepatic resection and liver transplantation 105
Electronic Outpatient Referral System for Liver Transplant Improves Appropriateness and Allows First Visit Triage 105
Temporal trends of waitlistings for liver transplantation in Italy: the ECALITA (Evolution of IndiCAtion in LIver transplantation in ITAly) registry study 102
An international multicentre study of protocols for liver transplantation during a pandemic: A case for quadripartite equipoise 102
First human liver transplantation using a marginal allograft resuscitated by normothermic machine perfusion 101
What Is the Role of Minimally Invasive Liver Surgery in Treating Patients with Hepatocellular Carcinoma on Cirrhosis? 100
Rescue liver transplantation after post-hepatectomy acute liver failure: A systematic review and pooled analysis 99
Adult liver transplantation in the congenital absence of inferior vena cava 99
Evaluation of Humoral Response following SARS-CoV-2 mRNA-Based Vaccination in Liver Transplant Recipients Receiving Tailored Immunosuppressive Therapy 99
The impact of center volume on the utilization and outcomes of machine perfusion technology in liver transplantation: An international survey 97
The Effects of Sustained Immunosuppression Withdrawal After Liver Transplantation on Metabolic Syndrome 97
The efficacy and safety of mammalian target of rapamycin inhibitors ab initio after liver transplantation without corticosteroids or induction therapy 97
Towards tolerance in liver transplantation 97
Awareness and Impact of Non-pharmaceutical Interventions During Coronavirus Disease 2019 Pandemic in Renal Transplant Recipients 94
How future surgery will benefit from SARS-COV-2-related measures: a SPIGC survey conveying the perspective of Italian surgeons 94
Global management of a common, underrated surgical task during the COVID-19 pandemic: Gallstone disease - An international survery 94
Graft weight integration in the early allograft dysfunction formula improves the prediction of early graft loss after liver transplantation 94
Higher retransplantation rate following extended right split-liver transplantation: An analysis from the eurotransplant liver follow-up registry 93
Primary Prophylaxis for Gastrointestinal Bleeding in Children With Biliary Atresia and Portal Hypertension Candidates for Liver Transplantation: A Single-Center Experience 91
Urological Complications in Kidney Transplant Recipients: Analysis of the Risk Factors and Impact on Transplant Outcomes in the Era of “Extended Criteria Donors” 90
Laparoscopic liver resection for hepatocellular carcinoma in Fontan-associated chronic liver disease. The first case report 90
Current management of hepatobiliary malignancies between centers with or without a liver transplant program: A multi-society national survey 89
Severe Unresolved Cholestasis Due to Unknown Etiology Leading to Early Allograft Failure Within the First 3 Months of Liver Transplantation 89
Feasibility and cost effectiveness of ambulatory laparoscopic cholecystectomy. A retrospective cohort study 88
The management of immunosuppression in kidney transplant recipients with COVID-19 disease: an update and systematic review of the literature 85
Vascular involvements in cholangiocarcinoma: tips and tricks 85
Minimally invasive hepatopancreatic and biliary surgery in children: a large centre experience and review of the literature 85
Maple Syrup Urine Disease and Domino Liver Transplantation: When and How? 82
Surgical management of colon cancer in ulcerative colitis patients with orthotopic liver transplant for primary sclerosing cholangitis. A systematic review 81
COVID-19 in a pregnant kidney transplant recipient - what we need to know: A case report 81
Normothermic Machine Perfusion of Deceased Donor Liver Grafts Is Associated with Improved Postreperfusion Hemodynamics 80
Life-saving vascular access after combined liver and kidney transplantation: A challenging access to the right atrium 80
Health economics aspects of kidney transplantation in Sicily: a benchmark analysis on activity and estimated savings 79
Heterogeneous indications and the need for viability assessment: An international survey on the use of machine perfusion in liver transplantation 76
Immunosuppression protocols for emerging oncological indications in liver transplantation: A systematic review and pooled analysis 74
Machine perfusion organ preservation: Highlights from the American Transplant Congress 2022 73
Totale 19.902
Categoria #
all - tutte 70.049
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 70.049


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022510 0 0 0 0 20 54 54 26 77 74 29 176
2022/2023794 82 61 7 72 72 167 70 126 50 11 50 26
2023/2024408 47 20 42 9 49 87 29 8 13 34 8 62
2024/20252.666 52 412 238 226 64 305 182 74 231 328 278 276
2025/20265.778 390 252 489 483 502 413 703 726 602 553 387 278
2026/20271.952 388 265 737 561 1 0 0 0 0 0 0 0
Totale 20.840